{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:59Z","timestamp":1788815279538,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118329","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:00:57Z","timestamp":1786021257000},"page":"118329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Hypoxia-activated endothelial cells drive stemness and vasculogenic mimicry in NSCLC via a HIF-1\u03b1\/ITPR3 axis"],"prefix":"10.1016","volume":"253","author":[{"given":"Wenhao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118329_b0005","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, T.B. Kratzer, N.S. Wagle, H. Sung, A. Jemal, Cancer statistics, 2026, CA: A Cancer J Clin., 76(1) (2026) e70043.","DOI":"10.3322\/caac.70043"},{"key":"10.1016\/j.bcp.2026.118329_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102315","article-title":"Cellular senescence in lung cancer: molecular mechanisms and therapeutic interventions","volume":"97","author":"Jha","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2026.118329_b0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.semcancer.2022.03.006","article-title":"Small cell lung cancer transformation: from pathogenesis to treatment","volume":"86","author":"Yin","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118329_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41571-022-00718-x","article-title":"At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC","volume":"20","author":"Otano","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7689","key":"10.1016\/j.bcp.2026.118329_b0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.bcp.2026.118329_b0035","doi-asserted-by":"crossref","first-page":"e1677","DOI":"10.1002\/wnan.1677","article-title":"A review on RNAi therapy for NSCLC: opportunities and challenges","volume":"13","author":"Kumar","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118329_b0040","doi-asserted-by":"crossref","first-page":"36940","DOI":"10.31083\/FBL36940","article-title":"Microenvironment of solid tumors","volume":"30","author":"Korneenko","year":"2025","journal-title":"Front. Biosci. (Landmark Edition)"},{"key":"10.1016\/j.bcp.2026.118329_b0045","article-title":"Interplay between solid tumors and tumor microenvironment","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118329_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","article-title":"Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118329_b0060","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","article-title":"CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma","volume":"82","author":"Lu","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118329_b0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2326-6066.CIR-21-0369","article-title":"Molecular signature of tumor-associated high endothelial venules that can predict breast cancer survival","volume":"10","author":"Sawada","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118329_b0070","first-page":"715","article-title":"Angiogenesis as a hallmark of solid tumors - clinical perspectives","volume":"44","author":"Majidpoor","year":"2021","journal-title":"Cellular Oncol. (Dordrecht, Netherlands)"},{"issue":"25","key":"10.1016\/j.bcp.2026.118329_b0075","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.7150\/jca.34171","article-title":"Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.118329_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107805","article-title":"Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - interest in making it a therapeutic target","volume":"223","author":"Treps","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118329_b0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41419-022-04814-9","article-title":"Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118329_b0095","article-title":"Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118329_b0100","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/gutjnl-2024-333638","article-title":"Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling","volume":"74","author":"Sun","year":"2025","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.bcp.2026.118329_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112791","article-title":"FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy","volume":"42","author":"Cannell","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0110","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220979","article-title":"Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency","volume":"222","author":"Blanco","year":"2025","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118329_b0115","article-title":"Angiogenesis causes and vasculogenic mimicry formation in the context of cancer stem cells","volume":"1880","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bcp.2026.118329_b0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s13238-011-1041-2","article-title":"Contribution of cancer stem cells to tumor vasculogenic mimicry","volume":"2","author":"Yao","year":"2011","journal-title":"Protein Cell"},{"issue":"11","key":"10.1016\/j.bcp.2026.118329_b0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"49","key":"10.1016\/j.bcp.2026.118329_b0130","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/s41388-023-02869-2","article-title":"Alleviating hypoxia to improve cancer immunotherapy","volume":"42","author":"Fan","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118329_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1481726","article-title":"Vasculogenic mimicry in non-small cell lung cancer: a systematic review","volume":"15","author":"Shapkina","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118329_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156437","article-title":"Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1\u03b1\/LARS1\/mTOR axis","volume":"139","author":"Zhao","year":"2025","journal-title":"Phytomed.: Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.bcp.2026.118329_b0150","doi-asserted-by":"crossref","DOI":"10.1177\/15347354251332590","article-title":"Mechanism of modified tongyou decoction and its separated formulas inhibiting vasculogenic mimicry in esophageal cancer TE-1 cells via NF-\u03baB\/HIF-1\u03b1 axis","volume":"24","author":"Wang","year":"2025","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118329_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2026.120874","article-title":"Tumor microenvironment and biomarker innovation in ovarian cancer: mechanistic insights into immune evasion, angiogenesis, and therapeutic resistance","volume":"584","author":"Liu","year":"2026","journal-title":"Clinica Chimica Acta; Int. J. Clin. Chem."},{"key":"10.1016\/j.bcp.2026.118329_b0160","doi-asserted-by":"crossref","unstructured":"J. Lacombe, S.E. Dunn, M. Layac, M. Soldevila, N.M. Fakrudin, B. Duane, et al., A human 3D culture-organ-on-chip platform for investigating the tumor microenvironment response to ionizing radiation, iScience 29(1) (2026) 114236.","DOI":"10.1016\/j.isci.2025.114236"},{"key":"10.1016\/j.bcp.2026.118329_b0165","doi-asserted-by":"crossref","unstructured":"Y. Sun, Z. Li, B. Yu, C. Zhang, L. Wang, B. Guo, et al., Increased excitability of layer 5 neocortical pyramidal neurons and its contribution to seizure activity in Gabrg2 gene-deficient mice, iScience 29(1) (2026) 114421.","DOI":"10.1016\/j.isci.2025.114421"},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-021-01866-1","article-title":"ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-\u0138B\/CD44 pathway in urinary bladder carcinoma","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exper. Clin. Cancer Res.: CR"},{"issue":"9","key":"10.1016\/j.bcp.2026.118329_b0175","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.devcel.2022.04.010","article-title":"Functional genetic screen identifies ITPR3\/calcium\/RELB axis as a driver of colorectal cancer metastatic liver colonization","volume":"57","author":"Moy","year":"2022","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12964-024-01550-9","article-title":"CD146(+)CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10\/JAK1\/STAT3 pathway","volume":"22","author":"Yu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","article-title":"Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0190","doi-asserted-by":"crossref","first-page":"14882","DOI":"10.1038\/s41598-024-64479-6","article-title":"Detrimental interactions of hypoxia and complement MASP-1 in endothelial cells as a model for atherosclerosis-related diseases","volume":"14","author":"Demeter","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118329_b0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118329_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-0716-2403-6_3","article-title":"In vitro tube formation assays in matrigel","volume":"2514","author":"Francescone","year":"2022","journal-title":"Methods Mol. Biol. (Clifton N.J.)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:17:03Z","timestamp":1788812223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0006295226006684"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118329","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia-activated endothelial cells drive stemness and vasculogenic mimicry in NSCLC via a HIF-1\u03b1\/ITPR3 axis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118329"}}